These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 11162341

  • 1. The cost-effectiveness of public postsecondary education subsidies.
    Muennig P, Fahs M.
    Prev Med; 2001 Feb; 32(2):156-62. PubMed ID: 11162341
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD, Holtgrave DR, Pinkerton HJ.
    Arch Intern Med; 1997 Sep 22; 157(17):1972-80. PubMed ID: 9308509
    [Abstract] [Full Text] [Related]

  • 4. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobágyi GN.
    Breast J; 2006 Sep 22; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [Abstract] [Full Text] [Related]

  • 5. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA, Winston FK, Kallan MJ, Branas CC, Schwartz JS.
    Ambul Pediatr; 2008 Sep 22; 8(1):58-65. PubMed ID: 18191783
    [Abstract] [Full Text] [Related]

  • 6. The cost-effectiveness of intensive national school-based anti-tobacco education: results from the tobacco policy model.
    Tengs TO, Osgood ND, Chen LL.
    Prev Med; 2001 Dec 22; 33(6):558-70. PubMed ID: 11716651
    [Abstract] [Full Text] [Related]

  • 7. Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis.
    Sullivan PW, Follin SL, Nichol MB.
    Med Care; 2003 Dec 22; 41(12):1382-95. PubMed ID: 14668671
    [Abstract] [Full Text] [Related]

  • 8. The Brookline Early Education Project: a 25-year follow-up study of a family-centered early health and development intervention.
    Palfrey JS, Hauser-Cram P, Bronson MB, Warfield ME, Sirin S, Chan E.
    Pediatrics; 2005 Jul 22; 116(1):144-52. PubMed ID: 15995045
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of community-based physical activity interventions.
    Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW, Teutsch S, Cawley J, Lee IM, West L, Buchner DM.
    Am J Prev Med; 2008 Dec 22; 35(6):578-88. PubMed ID: 19000846
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.
    Vaccine; 2004 Mar 12; 22(9-10):1138-49. PubMed ID: 15003641
    [Abstract] [Full Text] [Related]

  • 14. Global cost-effectiveness of cataract surgery.
    Lansingh VC, Carter MJ, Martens M.
    Ophthalmology; 2007 Sep 12; 114(9):1670-8. PubMed ID: 17383730
    [Abstract] [Full Text] [Related]

  • 15. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK, Hutton G, Das Dores Pascoal E.
    Health Policy Plan; 2005 Jan 12; 20(1):50-9. PubMed ID: 15689430
    [Abstract] [Full Text] [Related]

  • 16. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS, Davis MM.
    Prev Med; 2006 Mar 12; 42(3):240-6. PubMed ID: 16480761
    [Abstract] [Full Text] [Related]

  • 17. Impact of public programs on fertility and gender specific investment in human capital of children in rural India: cross sectional and time series analyses.
    Duraisamy P, Malathy R.
    Res Popul Econ; 1991 Mar 12; 7():157-87. PubMed ID: 12317027
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D, WHO-CHOICE.
    Epilepsia; 2005 May 12; 46(5):751-9. PubMed ID: 15857443
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.